Medical Director of the Melanoma Institute Australia, Professor Georgina Long, spoke with Mark Levy about a groundbreaking clinical trial that has delivered extraordinary results for patients diagnosed with advanced melanoma.
2025
Lipson Discusses Treatment Selection, Toxicity, and Duration of IO in Melanoma
During a Case-Based Roundtable® event, Evan J. Lipson, MD, moderated a discussion on the tolerability of immunotherapy in metastatic melanoma and when to stop therapy.
Observation Is a Reasonable Alternative to Adjuvant PD-1 Blockade in Stage IIB/IIIC Melanoma
Tara C. Mitchell, MD, discusses considerations and lingering questions regarding pre- and post-operative management strategies in stage IIB/IIIC melanoma.
Melanoma Patients’ Given New Hope With Ground-Breaking Clinical Trial | 10 News First
Melanoma patients with some of the worst diagnoses having seen the disease spread to their brains are tonight being given a major boost of hope, all thanks to a ground-breaking clinical trial.